Trials / Completed
CompletedNCT00712907
Effects of Vitamin C on Hyperoxia-Induced Reduction of Retinal Blood Flow
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- Male
- Age
- 19 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
High arterial blood oxygen tension leads to vasoconstriction of retinal vessels, possibly related to an interaction between reactive oxygen species and endothelium-derived vasoactive factors. Vitamin C is a potent antioxidant capable of reversing endothelial dysfunction due to increased oxidant stress. Vitamin C appears to have vasodilatory properties, but the underlying mechanisms are not well understood. In the present study we hypothesized that hyperoxic vasoconstriction of retinal vessels could be diminished by vitamin C. Ocular blood flow will be determined by non-invasive methods, including laser Doppler velocimetry and the Zeiss retinal vessel analyser.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | vitamin C (Mayrhofer) 24mg/min i.v. for 64 min | Substance: Ascorbic acid (Mayrhofer) Manufacturer: Mayrhofer, Linz, Austria Dosage form: i.v. Dosage: 24mg/min over 64 min Dosage reference: Ting HH 1996 |
| DIETARY_SUPPLEMENT | Placebo | Substance: Physiologic saline solution 0.9% (placebo) Dosage form: i.v. Dosage: 24ml/min over 64 min |
| OTHER | 100% O2 (AGA) two times for 12 min | Substance: 100% oxygen (AGA, Vienna, Austria, gases for human use) Manufacturer: AGA, Vienna, Austria, gases for human use Dosage form: Inhalation through an oxygenmask over a period of 12 minutes two times per study day. Dosage reference: Strenn K 1997 |
Timeline
- Start date
- 2003-02-01
- Primary completion
- 2003-05-01
- Completion
- 2003-05-01
- First posted
- 2008-07-10
- Last updated
- 2008-07-10
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT00712907. Inclusion in this directory is not an endorsement.